Transitional cell carcinoma in dialysis patients

Jiann-Hui Ou, Cheng Chin Pan, Johnny Shinn Nan Lin, Tzong Shin Tzai, Wen-Horng Yang, Chien Chen Chang, Hong-Lin Cheng, YungMing Lin, Yat-Ching Tong

研究成果: Article

65 引文 (Scopus)

摘要

Objective: The aim of our study was to determine whether there is an increased incidence of urothelial cancer, especially transitional cell carcinoma (TCC), in uremic patients on dialysis. Methods: Retrospective chart analyses were completed for 1910 uremic patients undergoing maintenance dialysis between January 1987 and December 1997. The incidence of urinary tract cancer was assessed. Only the patients with cancers diagnosed after start of dialysis were enrolled in the study. Results. Of the 1910 patients, 70 had concomitant urinary tract cancers. Nineteen patients (0.99), including 17 patients with TCC and 2 patients with renal cell carcinoma, were diagnosed after the initiation of dialysis. The average duration from dialysis to TCC diagnosis was 38.3 (range 2-144) months. Painless gross hematuria was the cardinal symptom in 16 of the 17 patients with TCC. in the 17 patients with TCC, no distant metastases were found at the time of diagnosis. Fourteen patients (82.3) were stage O or A, and 1 patient was stage B1. Conclusions: The 0.89 incidence of TCC in our dialysis patients was high as compared with that of the general population. The risks of developing urinary TCC in dialysis patients were examined, and we suggest that immunosuppressive stage, dialysis procedure, and chronic bladder irritation (decreased urinary wash effect) may play a part in the development of urinary TCC in dialysis patients. Early detection of hematuria due to regular visits and decreased exposure of urinary tract epithelium to carcinogens from urine may explain why early-stage TCC was seen in most of our patients. Copyright (C) 2000 S. Karger AG, Basel.

原文English
頁(從 - 到)90-94
頁數5
期刊European Urology
37
發行號1
DOIs
出版狀態Published - 2000 一月 1

指紋

Transitional Cell Carcinoma
Dialysis
Urologic Neoplasms
Hematuria
Incidence
Urothelium
Immunosuppressive Agents
Renal Cell Carcinoma
Carcinogens

All Science Journal Classification (ASJC) codes

  • Urology

引用此文

Ou, Jiann-Hui ; Pan, Cheng Chin ; Lin, Johnny Shinn Nan ; Tzai, Tzong Shin ; Yang, Wen-Horng ; Chang, Chien Chen ; Cheng, Hong-Lin ; Lin, YungMing ; Tong, Yat-Ching. / Transitional cell carcinoma in dialysis patients. 於: European Urology. 2000 ; 卷 37, 編號 1. 頁 90-94.
@article{ba5b1018d3d84c8e91c9c6b4b80d33aa,
title = "Transitional cell carcinoma in dialysis patients",
abstract = "Objective: The aim of our study was to determine whether there is an increased incidence of urothelial cancer, especially transitional cell carcinoma (TCC), in uremic patients on dialysis. Methods: Retrospective chart analyses were completed for 1910 uremic patients undergoing maintenance dialysis between January 1987 and December 1997. The incidence of urinary tract cancer was assessed. Only the patients with cancers diagnosed after start of dialysis were enrolled in the study. Results. Of the 1910 patients, 70 had concomitant urinary tract cancers. Nineteen patients (0.99), including 17 patients with TCC and 2 patients with renal cell carcinoma, were diagnosed after the initiation of dialysis. The average duration from dialysis to TCC diagnosis was 38.3 (range 2-144) months. Painless gross hematuria was the cardinal symptom in 16 of the 17 patients with TCC. in the 17 patients with TCC, no distant metastases were found at the time of diagnosis. Fourteen patients (82.3) were stage O or A, and 1 patient was stage B1. Conclusions: The 0.89 incidence of TCC in our dialysis patients was high as compared with that of the general population. The risks of developing urinary TCC in dialysis patients were examined, and we suggest that immunosuppressive stage, dialysis procedure, and chronic bladder irritation (decreased urinary wash effect) may play a part in the development of urinary TCC in dialysis patients. Early detection of hematuria due to regular visits and decreased exposure of urinary tract epithelium to carcinogens from urine may explain why early-stage TCC was seen in most of our patients. Copyright (C) 2000 S. Karger AG, Basel.",
author = "Jiann-Hui Ou and Pan, {Cheng Chin} and Lin, {Johnny Shinn Nan} and Tzai, {Tzong Shin} and Wen-Horng Yang and Chang, {Chien Chen} and Hong-Lin Cheng and YungMing Lin and Yat-Ching Tong",
year = "2000",
month = "1",
day = "1",
doi = "10.1159/000020106",
language = "English",
volume = "37",
pages = "90--94",
journal = "European Urology",
issn = "0302-2838",
publisher = "Elsevier",
number = "1",

}

Transitional cell carcinoma in dialysis patients. / Ou, Jiann-Hui; Pan, Cheng Chin; Lin, Johnny Shinn Nan; Tzai, Tzong Shin; Yang, Wen-Horng; Chang, Chien Chen; Cheng, Hong-Lin; Lin, YungMing; Tong, Yat-Ching.

於: European Urology, 卷 37, 編號 1, 01.01.2000, p. 90-94.

研究成果: Article

TY - JOUR

T1 - Transitional cell carcinoma in dialysis patients

AU - Ou, Jiann-Hui

AU - Pan, Cheng Chin

AU - Lin, Johnny Shinn Nan

AU - Tzai, Tzong Shin

AU - Yang, Wen-Horng

AU - Chang, Chien Chen

AU - Cheng, Hong-Lin

AU - Lin, YungMing

AU - Tong, Yat-Ching

PY - 2000/1/1

Y1 - 2000/1/1

N2 - Objective: The aim of our study was to determine whether there is an increased incidence of urothelial cancer, especially transitional cell carcinoma (TCC), in uremic patients on dialysis. Methods: Retrospective chart analyses were completed for 1910 uremic patients undergoing maintenance dialysis between January 1987 and December 1997. The incidence of urinary tract cancer was assessed. Only the patients with cancers diagnosed after start of dialysis were enrolled in the study. Results. Of the 1910 patients, 70 had concomitant urinary tract cancers. Nineteen patients (0.99), including 17 patients with TCC and 2 patients with renal cell carcinoma, were diagnosed after the initiation of dialysis. The average duration from dialysis to TCC diagnosis was 38.3 (range 2-144) months. Painless gross hematuria was the cardinal symptom in 16 of the 17 patients with TCC. in the 17 patients with TCC, no distant metastases were found at the time of diagnosis. Fourteen patients (82.3) were stage O or A, and 1 patient was stage B1. Conclusions: The 0.89 incidence of TCC in our dialysis patients was high as compared with that of the general population. The risks of developing urinary TCC in dialysis patients were examined, and we suggest that immunosuppressive stage, dialysis procedure, and chronic bladder irritation (decreased urinary wash effect) may play a part in the development of urinary TCC in dialysis patients. Early detection of hematuria due to regular visits and decreased exposure of urinary tract epithelium to carcinogens from urine may explain why early-stage TCC was seen in most of our patients. Copyright (C) 2000 S. Karger AG, Basel.

AB - Objective: The aim of our study was to determine whether there is an increased incidence of urothelial cancer, especially transitional cell carcinoma (TCC), in uremic patients on dialysis. Methods: Retrospective chart analyses were completed for 1910 uremic patients undergoing maintenance dialysis between January 1987 and December 1997. The incidence of urinary tract cancer was assessed. Only the patients with cancers diagnosed after start of dialysis were enrolled in the study. Results. Of the 1910 patients, 70 had concomitant urinary tract cancers. Nineteen patients (0.99), including 17 patients with TCC and 2 patients with renal cell carcinoma, were diagnosed after the initiation of dialysis. The average duration from dialysis to TCC diagnosis was 38.3 (range 2-144) months. Painless gross hematuria was the cardinal symptom in 16 of the 17 patients with TCC. in the 17 patients with TCC, no distant metastases were found at the time of diagnosis. Fourteen patients (82.3) were stage O or A, and 1 patient was stage B1. Conclusions: The 0.89 incidence of TCC in our dialysis patients was high as compared with that of the general population. The risks of developing urinary TCC in dialysis patients were examined, and we suggest that immunosuppressive stage, dialysis procedure, and chronic bladder irritation (decreased urinary wash effect) may play a part in the development of urinary TCC in dialysis patients. Early detection of hematuria due to regular visits and decreased exposure of urinary tract epithelium to carcinogens from urine may explain why early-stage TCC was seen in most of our patients. Copyright (C) 2000 S. Karger AG, Basel.

UR - http://www.scopus.com/inward/record.url?scp=0033980420&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033980420&partnerID=8YFLogxK

U2 - 10.1159/000020106

DO - 10.1159/000020106

M3 - Article

C2 - 10671792

AN - SCOPUS:0033980420

VL - 37

SP - 90

EP - 94

JO - European Urology

JF - European Urology

SN - 0302-2838

IS - 1

ER -